Animi

Lages 88501-001

0 studies enrolling now · 2 studies all time

What they study most

Advanced Cutaneous Squamous Cell Carcinoma, Metastatic Renal Cell Carcinoma, Renal Cell Carcinoma

Studies at this site

• Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma — Completed
• A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC) — Stopped early